Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • AbbVie opts for North Carolina to house $1.4bn manufacturing site
  • Manufacturing

AbbVie opts for North Carolina to house $1.4bn manufacturing site

Pharmaceutical Technology

This Durham-based facility will be AbbVie's first manufacturing site in the state, and will become a centre of excellence for SVP production.

ManufacturingRead full story

pharminent April 23, 2026 (Last updated: April 23, 2026)

Pharmaceutical Technology

This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production.

ManufacturingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: MSD teams up with Google Cloud on agentic AI transformation
Next: Sanofi receives FDA approval for Tzield in paediatric diabetes

Related Stories

  • Manufacturing

Lilly and Resilience invest $750M in diabetes and obesity drug device supply

pharminent July 31, 2026
  • Manufacturing

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

pharminent July 29, 2026
  • Manufacturing

GSK to quit Stevenage for new R&D site in Cambridge

pharminent July 28, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.